Atrial Fibrillation Trial, Recruiting NCT06847932 Sponsor: National Defense Medical Center, Taiwan Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06847932
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are either admitted to a hospital or attending as an outpatient.
  • People who have had at least one electrocardiogram (a heart tracing test, often called an ECG) within the past year.

Who may not be able to join:

  • People who have been diagnosed with atrial fibrillation or atrial flutter (types of irregular heart rhythms).
  • People who have previously had a catheter ablation procedure to treat atrial fibrillation or atrial flutter.
  • People who have an implanted heart device, such as a pacemaker or defibrillator.
  • People whose ECG records have ever shown atrial fibrillation, atrial flutter, or a pacing rhythm (a heartbeat controlled by a device).
  • People who have previously been treated with certain medications used to control heart rhythm problems, specifically Class I or Class III antiarrhythmic drugs (confirm with trial site if unsure whether a past medication falls into these categories).
  • People for whom a doctor has identified a reason to prescribe blood-thinning medication, including warfarin-type drugs (vitamin K antagonists) or newer oral blood thinners (non-vitamin K antagonist oral anticoagulants).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chin Lin, PhD, National Defense Medical Center

Phone: +886-2-8792-3100 Ext. 18574

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Defense Medical Center, Taiwan
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Latent atrial fibrillation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov